Editas Medicine, Inc. (EDIT) Revenue 2016–2025
Editas Medicine, Inc. (EDIT) annual revenue history from SEC filings — each fiscal year as reported, with year-over-year change.
$40.5MFY2025 · since FY2016: $6.1M → $40.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $40.5M | +25.4% |
| FY2024 | $32.3M | -58.6% |
| FY2023 | $78.1M | +296.3% |
| FY2022 | $19.7M | -22.8% |
| FY2021 | $25.5M | -71.8% |
| FY2020 | $90.7M | +341.9% |
| FY2019 | $20.5M | -35.7% |
| FY2018 | $31.9M | +132.6% |
| FY2017 | $13.7M | +126.8% |
| FY2016 | $6.1M | — |
Source: SEC XBRL filings · For reference only · Not investment advice